Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10090 | 1093 | 46.6 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
66 | 3 | LEPTIN//ADIPONECTIN//ENDOCRINOLOGY & METABOLISM | 84415 |
2141 | 2 | FATTY ACID SYNTHASE//LIVER X RECEPTOR//LXR | 5046 |
10090 | 1 | LIVER X RECEPTOR//LXR//T0901317 | 1093 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LIVER X RECEPTOR | authKW | 3578347 | 23% | 51% | 249 |
2 | LXR | authKW | 1470976 | 12% | 41% | 129 |
3 | T0901317 | authKW | 624311 | 3% | 72% | 31 |
4 | GW3965 | authKW | 363163 | 1% | 100% | 13 |
5 | LXR AGONIST | authKW | 310503 | 2% | 65% | 17 |
6 | LXR ALPHA | authKW | 292473 | 3% | 32% | 33 |
7 | NUCL RECEPTORS CELL SIGNALING | address | 269293 | 4% | 20% | 49 |
8 | UMR 1103 | address | 201127 | 1% | 60% | 12 |
9 | LIVER X RECEPTOR LXR | authKW | 174408 | 1% | 39% | 16 |
10 | LXR BETA | authKW | 160952 | 1% | 52% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 1686 | 35% | 0% | 379 |
2 | Endocrinology & Metabolism | 1306 | 14% | 0% | 156 |
3 | Cell Biology | 801 | 15% | 0% | 169 |
4 | Chemistry, Medicinal | 563 | 7% | 0% | 81 |
5 | Peripheral Vascular Diseases | 312 | 6% | 0% | 62 |
6 | Biophysics | 176 | 6% | 0% | 62 |
7 | Pharmacology & Pharmacy | 168 | 10% | 0% | 107 |
8 | Hematology | 167 | 5% | 0% | 50 |
9 | Medicine, Research & Experimental | 160 | 6% | 0% | 62 |
10 | Immunology | 89 | 6% | 0% | 68 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUCL RECEPTORS CELL SIGNALING | 269293 | 4% | 20% | 49 |
2 | UMR 1103 | 201127 | 1% | 60% | 12 |
3 | UMR 6293 | 102614 | 1% | 28% | 13 |
4 | PROGRAM IMMUNOL BIO IMMUNO GENE THER Y CANC | 83807 | 0% | 100% | 3 |
5 | BIOSCI NUTR | 74580 | 6% | 4% | 68 |
6 | BIO TRANSFORMAT DISPOSIT | 55871 | 0% | 100% | 2 |
7 | ENDOCRINOL PL | 55871 | 0% | 100% | 2 |
8 | GRP MUERTE CELULAR | 55871 | 0% | 100% | 2 |
9 | AREA NEUROBIOL CELULAR MOL | 50282 | 0% | 60% | 3 |
10 | GRED | 48430 | 1% | 12% | 14 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF LIPID RESEARCH | 4689 | 3% | 0% | 38 |
2 | MOLECULAR ENDOCRINOLOGY | 2593 | 2% | 0% | 23 |
3 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2301 | 2% | 0% | 25 |
4 | CELL METABOLISM | 1539 | 1% | 1% | 9 |
5 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 1024 | 1% | 0% | 10 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 825 | 3% | 0% | 28 |
7 | MOLECULAR NEURODEGENERATION | 793 | 0% | 1% | 4 |
8 | FUTURE LIPIDOLOGY | 708 | 0% | 1% | 2 |
9 | JOURNAL OF BIOLOGICAL CHEMISTRY | 663 | 6% | 0% | 64 |
10 | CLINICAL LIPIDOLOGY | 652 | 0% | 1% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIVER X RECEPTOR | 3578347 | 23% | 51% | 249 | Search LIVER+X+RECEPTOR | Search LIVER+X+RECEPTOR |
2 | LXR | 1470976 | 12% | 41% | 129 | Search LXR | Search LXR |
3 | T0901317 | 624311 | 3% | 72% | 31 | Search T0901317 | Search T0901317 |
4 | GW3965 | 363163 | 1% | 100% | 13 | Search GW3965 | Search GW3965 |
5 | LXR AGONIST | 310503 | 2% | 65% | 17 | Search LXR+AGONIST | Search LXR+AGONIST |
6 | LXR ALPHA | 292473 | 3% | 32% | 33 | Search LXR+ALPHA | Search LXR+ALPHA |
7 | LIVER X RECEPTOR LXR | 174408 | 1% | 39% | 16 | Search LIVER+X+RECEPTOR+LXR | Search LIVER+X+RECEPTOR+LXR |
8 | LXR BETA | 160952 | 1% | 52% | 11 | Search LXR+BETA | Search LXR+BETA |
9 | OXYSTEROLS | 146844 | 6% | 8% | 66 | Search OXYSTEROLS | Search OXYSTEROLS |
10 | LIVER X RECEPTOR ALPHA | 144905 | 2% | 25% | 21 | Search LIVER+X+RECEPTOR+ALPHA | Search LIVER+X+RECEPTOR+ALPHA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TICE, CM , NOTO, PB , FAN, KY , ZHUANG, LH , LALA, DS , SINGH, SB , (2014) THE MEDICINAL CHEMISTRY OF LIVER X RECEPTOR (LXR) MODULATORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 57. ISSUE 17. P. 7182 -7205 | 118 | 77% | 8 |
2 | JAKOBSSON, T , TREUTER, E , GUSTAFSSON, JA , STEFFENSEN, KR , (2012) LIVER X RECEPTOR BIOLOGY AND PHARMACOLOGY: NEW PATHWAYS, CHALLENGES AND OPPORTUNITIES.TRENDS IN PHARMACOLOGICAL SCIENCES. VOL. 33. ISSUE 7. P. 394 -404 | 93 | 74% | 92 |
3 | VIENNOIS, E , MOUZAT, K , DUFOUR, J , MOREL, L , LOBACCARO, JM , BARON, S , (2012) SELECTIVE LIVER X RECEPTOR MODULATORS (SLIMS): WHAT USE IN HUMAN HEALTH?.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 351. ISSUE 2. P. 129-141 | 90 | 74% | 45 |
4 | VAN GILST, WH , DE BOER, RA , CANNON, MV , (2016) EMERGING ROLE OF LIVER X RECEPTORS IN CARDIAC PATHOPHYSIOLOGY AND HEART FAILURE.BASIC RESEARCH IN CARDIOLOGY. VOL. 111. ISSUE 1. P. - | 101 | 71% | 0 |
5 | STEFFENSEN, KR , JAKOBSSON, T , GUSTAFSSON, JA , (2013) TARGETING LIVER X RECEPTORS IN INFLAMMATION.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 17. ISSUE 8. P. 977 -990 | 92 | 74% | 16 |
6 | BARANOWSKI, M , (2008) BIOLOGICAL ROLE OF LIVER X RECEPTORS.JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 59. ISSUE 4. P. 31-55 | 87 | 70% | 119 |
7 | LIN, CY , GUSTAFSSON, JA , (2015) TARGETING LIVER X RECEPTORS IN CANCER THERAPEUTICS.NATURE REVIEWS CANCER. VOL. 15. ISSUE 4. P. 216 -224 | 68 | 72% | 16 |
8 | LIN, CY , VEDIN, LL , STEFFENSEN, KR , (2016) THE EMERGING ROLES OF LIVER X RECEPTORS AND THEIR LIGANDS IN CANCER.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 20. ISSUE 1. P. 61 -71 | 77 | 78% | 0 |
9 | HONG, C , TONTONOZ, P , (2014) LIVER X RECEPTORS IN LIPID METABOLISM: OPPORTUNITIES FOR DRUG DISCOVERY.NATURE REVIEWS DRUG DISCOVERY. VOL. 13. ISSUE 6. P. 433 -444 | 76 | 52% | 74 |
10 | VIENNOIS, E , POMMIER, AJC , MOUZAT, K , OUMEDDOUR, A , EL HAJJAJI, FZ , DUFOUR, J , CAIRA, F , VOLLE, DH , BARON, S , LOBACCARO, JMA , (2011) TARGETING LIVER X RECEPTORS IN HUMAN HEALTH: DEADLOCK OR PROMISING TRAIL?.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 15. ISSUE 2. P. 219-232 | 77 | 74% | 32 |
Classes with closest relation at Level 1 |